MedPath

Online Cognitive Control Training for Remitted Depressed Patients

Not Applicable
Completed
Conditions
Major Depression in Remission
Interventions
Behavioral: Cognitive control training
Behavioral: Active control training
Registration Number
NCT03278756
Lead Sponsor
University Ghent
Brief Summary

This study evaluates the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients. Half of the participants will receive a cognitive control training, while the other half will receive a low cognitive load training that acts as an active control condition.

Detailed Description

Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD (major depressive disorder) and RMD (remitted depressed) samples. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether an internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients.

A computer training, consisting of 10 sessions of 15 minutes each, will be administered to participants, which are remitted depressed patients. This training can either be a cognitive control training, using an adaptive paced auditory serial addition task, or an active control training, with a low cognitive load task.

Dependent variables will be assessed pre- and post-training, as well as 3 and 6 months after the training, and consist of depressive symptomatology, related variables and cognitive control measures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • History of ≥ 1 depressive episodes (major or bipolar)
  • Currently in stable full or partial remission (≥ 3 months)
Exclusion Criteria
  • Major depressive disorder (current or less than 3 months in remission)
  • Bipolar disorder (current or less than 3 months in remission)
  • Psychotic disorder (current and/or previous)
  • Neurological impairments (current and/or previous)
  • Excessive substance abuse (current and/or previous)
  • No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency of less than once every three weeks)
  • Use of antidepressant medication is allowed if kept at a constant level

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Control TrainingCognitive control trainingA cognitive control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive paced auditory serial addition task, where participants need to click on the sum of the last two heard digits.
Active Control TrainingActive control trainingAn active control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive low load cognitive task, where participants need to click on the last heard digit.
Primary Outcome Measures
NameTimeMethod
Change in depressive symptomatologyAssessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up

Measured by the Depression Anxiety Stress Scales (DASS)

Change in depressive rumination (brooding)Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Ruminative Response Scale (RRS), especially the brooding subscale

Secondary Outcome Measures
NameTimeMethod
Change in cognitive emotion regulation strategiesAssessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Cognitive Emotion Regulation Questionnaire (CERQ)

ResilienceAssessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Connor-Davidson Resilience Scale (CD-RISC)

Change in quality of lifeAssessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Quality of Life in Depression Scale (QLDS)

Remission from depressionAssessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Remission of Depression Questionnaire (RDQ)

Trial Locations

Locations (1)

Ghent University

🇧🇪

Gent, Oost-Vlaanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath